Marathon Asset Management Ltd Has $16.65 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Marathon Asset Management Ltd cut its holdings in Teleflex Incorporated (NYSE:TFX) by 4.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 93,534 shares of the medical technology company’s stock after selling 3,905 shares during the quarter. Marathon Asset Management Ltd owned about 0.20% of Teleflex worth $16,647,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of TFX. Janus Henderson Group PLC grew its position in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the period. FMR LLC lifted its stake in Teleflex by 70.1% in the 3rd quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock valued at $66,650,000 after acquiring an additional 111,086 shares in the last quarter. Point72 Asset Management L.P. lifted its stake in Teleflex by 31.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after acquiring an additional 96,958 shares in the last quarter. Parkman Healthcare Partners LLC bought a new stake in Teleflex in the 3rd quarter valued at approximately $23,778,000. Finally, Robeco Institutional Asset Management B.V. lifted its stake in Teleflex by 1,401.5% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 41,726 shares of the medical technology company’s stock valued at $7,426,000 after acquiring an additional 38,947 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Down 4.7 %

Shares of Teleflex stock opened at $132.58 on Monday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock has a market cap of $6.16 billion, a P/E ratio of 26.36, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $130.60 and a 12-month high of $249.90. The business’s 50 day moving average is $175.44 and its 200-day moving average is $204.65.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Equities research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s payout ratio is presently 95.77%.

Wall Street Analysts Forecast Growth

Several research firms have commented on TFX. Royal Bank of Canada cut Teleflex from an “outperform” rating to a “sector perform” rating and cut their target price for the company from $220.00 to $155.00 in a research note on Friday. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research note on Friday. Raymond James cut Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday. Piper Sandler restated a “neutral” rating and issued a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday. Finally, Truist Financial dropped their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Nine equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $196.83.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.